Rezultati - Walter Reinisch
- Showing 1 - 20 results of 159
- Go to Next Page
-
1
-
2
Biosimilar safety factors in clinical practice od Walter Reinisch, Josef S Smolen
Izdano 2015Artigo -
3
Interleukin 13 and its role in gut defence and inflammation od Peter Mannon, Walter Reinisch
Izdano 2012Revisão -
4
-
5
-
6
-
7
-
8
Competition for Clinical Trials in Inflammatory Bowel Diseases od M. Scott Harris, Jolanta Wichary, Matt Zadnik, Walter Reinisch
Izdano 2019Editorial -
9
-
10
-
11
-
12
-
13
-
14
-
15
Systematic Review od Neeraj Narula, Michael Fine, Jean‐Frédéric Colombel, John K. Marshall, Walter Reinisch
Izdano 2015Revisão -
16
-
17
-
18
Systematic Review and Meta-analysis od Neeraj Narula, Zain Kassam, Yuhong Yuan, Jean‐Frédéric Colombel, Cyriel Ponsioen, Walter Reinisch, Paul Moayyedi
Izdano 2017Revisão -
19
-
20
52-Week Efficacy of Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis Who Failed Corticosteroids and/or Immunosuppressants od Walter Reinisch, William J. Sandborn, Remo Panaccione, Bidan Huang, Paul F. Pollack, Andreas Lazar, Roopal Thakkar
Izdano 2013Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Disease
Gastroenterology
Inflammatory bowel disease
Ulcerative colitis
Crohn's disease
Pathology
Surgery
Alternative medicine
Placebo
Immunology
Infliximab
Clinical trial
Adverse effect
Randomized controlled trial
Intensive care medicine
Adalimumab
Biology
Clinical endpoint
Colitis
Rheumatoid arthritis
Tumor necrosis factor alpha
Azathioprine
Cancer
Environmental health
Physics
Inflammatory Bowel Diseases
Population
Colorectal cancer